Here's our story

Actevna® started out as a collaboration between friends and family to fix issues we experienced with conventional skincare, and to provide a better alternative.

95% of women use conventional skincare, but few are happy with their skin - whether its complexion, dryness, or breakouts. Up to 70% report sensitised skin.1-4


Ideally, there would be no need for skincare. After all, we evolved for millions of years without it. However, there's a genuine need for it, driven by changes to our daily environment, longer lifespans and a deep-rooted wish to be desired.

So we made Actevna®. It's biology’s solution to the skincare problem.

We hope you'll like our products as much as your skin does.

[1] “The Prevalence of Sensitive Skin” [2019]. Farage MA et al. Frontiers in Medicine.


[2] “The Prevalence of Self-Declared Sensitive Skin: A Systematic Review and Meta-Analysis” [2019]. Chen W et al. Journal of the European Academy of Dermatology and Venereology.


[3] “Sensitive Skin Syndrome: An Update” [2019]. Le Hahn DD et al. American Journal of Clinical Dermatology.


[4] “Psychological Aspects of Sensitive Skin: A Vicious Cycle” [2022]. Farage MA et al. Cosmetics.

Here's our story

Actevna® started out as a collaboration between friends and family to fix issues we experienced with conventional skincare, and to provide a better alternative.

95% of women use conventional skincare, but few are happy with their skin (complexion, dryness, breakouts etc.)


Up to 70% report sensitised skin. 1-4 Ideally, there would be no need for skincare - after all, we evolved without it. However, changes to our daily environment, the environment, longer lifespans, and a deep-rooted wish to be desired all drive a genuine need for it.

So we made Actevna®. It's biology’s solution to the skincare problem.

We hope you'll like our products as much as your skin does.

[1] “The Prevalence of Sensitive Skin” [2019]. Farage MA et al. Frontiers in Medicine.


[2] “The Prevalence of Self-Declared Sensitive Skin: A Systematic Review and Meta-Analysis” [2019]. Chen W et al. Journal of the European Academy of Dermatology and Venereology.


[3] “Sensitive Skin Syndrome: An Update” [2019]. Le Hahn DD et al. American Journal of Clinical Dermatology.


[4] “Psychological Aspects of Sensitive Skin: A Vicious Cycle” [2022]. Farage MA et al. Cosmetics.

Here's our story

Actevna® started out as a collaboration between friends and family to fix issues we experienced with conventional skincare, and to provide a better alternative.

95% of women use conventional skincare, but few are happy with their skin - whether its complexion, dryness, or breakouts. Up to 70% report sensitised skin.1-4


Ideally, there would be no need for skincare. After all, we evolved for millions of years without it. However, there's a genuine need for it, driven by changes to our daily environment, longer lifespans and a deep-rooted wish to be desired.

[1] “The Prevalence of Sensitive Skin” [2019]. Farage MA et al. Frontiers in Medicine.


[2] “The Prevalence of Self-Declared Sensitive Skin: A Systematic Review and Meta-Analysis” [2019]. Chen W et al. Journal of the European Academy of Dermatology and Venereology.


[3] “Sensitive Skin Syndrome: An Update” [2019]. Le Hahn DD et al. American Journal of Clinical Dermatology.


[4] “Psychological Aspects of Sensitive Skin: A Vicious Cycle” [2022]. Farage MA et al. Cosmetics.

Who we are

Core Team

Founder | CEO
LL.B, MBA (LBS)

Richard Straughan

Co-Founder | CPO

Christopher Straughan

CSO
MSc, PhD

Dr Kim Roberts

Growth
Bsc

Anna Priadka

Contributors

“If I have seen further, it is by standing on the shoulders of giants.”

— Sir Isaac Newton

Dr D.W. Straughan OBE

PhD, MB, BS

During a distinguished 60 year medical-scientific career, Dr Straughan co-authored the Animals (Scientific Procedures) Act [1986] - a progressive animal rights law to stop cruelty and unnecessary suffering.


This world-leading law and the FRAME lobby to the EU resulted in a 1993 Directive to ban animal tests for cosmetics. The UK began the ban in 1998 and other EU Member States started the ban in 2014.

Dr Mohi Rezvani

PhD, CBiol, FSB, MCPP

Dr Rezvani is a Reader Emeritus at the University of Oxford, and formerly led its Research Institute at Churchill Hospital.


For over 40 years, he has been a senior cell biologist and medical herbalist, specialising in the fields of radiobiology (skin cancer), stem cell and extracellular vesicle biology. Notably, Dr Rezvani pioneered work with Curcuma longa extract for the treatment of radiation skin lesion, among other herb-based skincare strategies for dermatological and cosmetic fields.


He is a fellow of the Royal Society of Medicine (RSM) the Royal Society of Biology (RSB).

Who we are

Core Team

Founder | CEO
LL.B, MBA (LBS)

Richard Straughan

Co-Founder | CPO

Christopher Straughan

CSO
MSc, PhD

Dr Kim Roberts

Growth
Bsc

Anna Priadka

Contributors

“If I have seen further, it is by standing on the shoulders of giants.”

— Sir Isaac Newton

Dr D.W. Straughan OBE

PhD, MB, BS

During a distinguished 60 year medical-scientific career, Dr Straughan co-authored the Animals (Scientific Procedures) Act [1986] - a progressive animal rights law to stop cruelty and unnecessary suffering.


This world-leading law and the FRAME lobby to the EU resulted in a 1993 Directive to ban animal tests for cosmetics. The UK began the ban in 1998 and other EU Member States started the ban in 2014.

Dr Mohi Rezvani

PhD, CBiol, FSB, MCPP

Dr Rezvani is a Reader Emeritus at the University of Oxford, and formerly led its Research Institute at Churchill Hospital.


For over 40 years, he has been a senior cell biologist and medical herbalist, specialising in the fields of radiobiology (skin cancer), stem cell and extracellular vesicle biology. Notably, Dr Rezvani pioneered work with Curcuma longa extract for the treatment of radiation skin lesion, among other herb-based skincare strategies for dermatological and cosmetic fields.


He is a fellow of the Royal Society of Medicine (RSM) the Royal Society of Biology (RSB).

Who we are

Core Team

Founder | CEO
LL.B, MBA (LBS)

Richard Straughan

Co-Founder | CPO

Christopher Straughan

CSO
MSc, PhD

Dr Kim Roberts

Growth
Bsc

Anna Priadka

Contributors

“If I have seen further, it is by standing on the shoulders of giants.”

— Sir Isaac Newton

Dr D.W. Straughan OBE

PhD, MB, BS

During a distinguished 60 year medical-scientific career, Dr Straughan co-authored the Animals (Scientific Procedures) Act [1986] - a progressive animal rights law to stop cruelty and unnecessary suffering.


This world-leading law and the FRAME lobby to the EU resulted in a 1993 Directive to ban animal tests for cosmetics. The UK began the ban in 1998 and other EU Member States started the ban in 2014.

Dr Mohi Rezvani

PhD, CBiol, FSB, MCPP

Dr Rezvani is a Reader Emeritus at the University of Oxford, and formerly led its Research Institute at Churchill Hospital.


For over 40 years, he has been a senior cell biologist and medical herbalist, specialising in the fields of radiobiology (skin cancer), stem cell and extracellular vesicle biology. Notably, Dr Rezvani pioneered work with Curcuma longa extract for the treatment of radiation skin lesion, among other herb-based skincare strategies for dermatological and cosmetic fields.


He is a fellow of the Royal Society of Medicine (RSM) the Royal Society of Biology (RSB).

© 2024 Actevna Ltd

© 2024 Actevna Ltd

© 2024 Actevna Ltd